Education
About Us
Working with TipRanks
Follow Us
Cardiff Oncology, Inc. (CRDF)
:CRDF
CRDF Analyst Ratings
Strong Buy
6 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRDF Stock 12 Month Forecast
Average Price Target
$9.00
▲(268.85% Upside)
| Highest Price Target$19.00 | Average Price Target$9.00 | Lowest Price Target$2.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$18→$10
Buy
309.84%
Upside
Reiterated
08/06/25
TR | OpenAI - 4o
$2.5
Hold
2.46%
Upside
Reiterated
08/02/25
William Blair
―
Buy
―
Reiterated
07/30/25
TD Cowen
―
Buy
―
Reiterated
07/29/25
Craig-Hallum
―
Buy
―
Reiterated
07/29/25
With Phase 2 data on vansertib and growing potential, Albert Lowe maintains a Buy rating on CRDF.
Ladenburg Thalmann & Co.
$19
Buy
678.69%
Upside
Initiated
07/08/25
Jefferies
$3.5
Hold
43.44%
Upside
Initiated
06/24/25
Piper Sandler
$10
Buy
309.84%
Upside
Reiterated
06/03/25
Lucid Capital
$14
Buy
473.77%
Upside
Initiated
04/03/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$18→$10
Buy
309.84%
Upside
Reiterated
08/06/25
TR | OpenAI - 4o
$2.5
Hold
2.46%
Upside
Reiterated
08/02/25
William Blair
―
Buy
―
Reiterated
07/30/25
TD Cowen
―
Buy
―
Reiterated
07/29/25
Craig-Hallum
―
Buy
―
Reiterated
07/29/25
With Phase 2 data on vansertib and growing potential, Albert Lowe maintains a Buy rating on CRDF.
Ladenburg Thalmann & Co.
$19
Buy
678.69%
Upside
Initiated
07/08/25
Jefferies
$3.5
Hold
43.44%
Upside
Initiated
06/24/25
Piper Sandler
$10
Buy
309.84%
Upside
Reiterated
06/03/25
Lucid Capital
$14
Buy
473.77%
Upside
Initiated
04/03/25
Best Analysts Covering Cardiff Oncology
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
+16.10%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +16.10% per trade.
3 Months
xxx
Success Rate
6/10 ratings generated profit
Average Return
+5.10%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +5.10% per trade.
1 Year
Success Rate
3/10 ratings generated profit
Average Return
-0.90%
reiterated a buy rating 20 days ago
Copying Marc Frahm's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -0.90% per trade.
2 Years
xxx
Success Rate
3/10 ratings generated profit
Average Return
+0.42%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 30.00% of your transactions generating a profit, with an average return of +0.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRDF Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
5
5
7
6
4
Buy
5
5
9
10
7
Hold
3
2
5
11
11
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
14
13
22
27
22
Each month's total comprises the sum of three months' worth of ratings.
CRDF Financial Forecast
CRDF Stock Forecast FAQ
What is CRDF’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardiff Oncology, Inc.’s 12-month average price target is 9.00.
What is CRDF’s upside potential, based on the analysts’ average price target?
Cardiff Oncology, Inc. has 268.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRDF a Buy, Sell or Hold?
Cardiff Oncology, Inc. has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cardiff Oncology, Inc.’s price target?
The average price target for Cardiff Oncology, Inc. is 9.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $19.00 ,the lowest forecast is $2.50. The average price target represents 268.85% Increase from the current price of $2.44.
The highest analyst price target is $19.00 ,the lowest forecast is $2.50. The average price target represents 268.85% Increase from the current price of $2.44.
What do analysts say about Cardiff Oncology, Inc.?
Cardiff Oncology, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CRDF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.